Skip to product information
Vitamin C 25 g

Vitamin C 25 g

Incl. VAT

Prescription

Presentation: 50 ml infusion concentrate

Composition: Sodium ascorbate 28.12 g (= 25 g vitamin C), water ad injectabilia

Prescription status: prescription only

Storage: does not require refrigeration

Shelf life: 1 year after manufacture

After completing your order, you will receive a link through which you can securely upload your prescription.

Anmeldung erforderlich
PRODUCT INFORMATION

Composition:

  • Sodium ascorbate 28.12 g (=25 g vitamin C) 
  • Water for injections up to 50 ml 

Administration: i.v., always prepare the infusion solution freshly dilute in 500ml body-temperature Ringer's lactate solution 

Infusion set: Intrafix © Air P 

Duration of infusion: 50-60 minutes 

Therapy interval: 1-2 times per week, based on the patient's health status 

Duration of treatment: 4-6 weeks, based on the patient's health status 

Storage: 15 – 25°C 

Shelf life: 1 year after manufacture

Side effects: Vitamin C can lead to falsely elevated blood sugar readings. Very rarely, high doses of ascorbic acid can cause gastrointestinal disturbances, such as nausea, vomiting, diarrhea. In individual cases, short-term circulatory disorders may occur. It can lead to an impairment of kidney function due to the formation of calcium oxalate crystals in the kidney. People with already impaired kidney function react more sensitively to this. 

THERAPY RECOMMENDATION

Positive effects: 

  • A 25 g vitamin C infusion has a prooxidant effect. Cytotoxic effect through the Fenton reaction. Vitamin C reduces iron(III) ions to iron(II) ions. The iron(II) ion reacts with oxygen to form superoxide. The decomposition of superoxide leads to H2O2. Hydrogen peroxide reacts with iron(II) ions to form hydroxyl radicals.
  • Cytotoxic effects: from 15–25 mmol/l (1–3 g/kg body weight)
  • High-dose vitamin C therapy has a therapeutically paradoxical effect. Healthy cells are protected by antioxidant action. Malignant cells are attacked by a prooxidant effect (H2O2 formation) and driven into apoptosis, the activity of the hypoxia-induced factor HIF is reduced, tumor suppressor proteins are upregulated, an increase in TET2 activity is possible, and the fermentative metabolism can be reduced.
  • Oncology patients often already have reduced antioxidant capacity before chemotherapy. In advanced tumor disease, the vitamin C level is often drastically reduced. High-dose vitamin C therapy can reduce the risk of secondary tumors, can enhance the effect of antineoplastic therapy, and resistances can be prevented.
  • Inflammatory processes can be significantly reduced.
  • Quality of life improvement: EORTC-QLQ 30, especially tissues that are sensitive to oxidative stress, such as the mucous membranes (nausea, vomiting, loss of appetite) and nerve tissue (fatigue, depression, sleep disorders), benefit from high-dose vitamin C.

Therapy recommendations: There is evidence that the properties of the substances contained in the product can have a positive effect on health disorders of the stated indications:

  • adjunctively in tumor therapy
  • prooxidant therapy
  • stimulation of mitochondrial biogenesis
  • in the early stages of bacterial and viral infections: The oxidative, immunomodulating effect of vitamin C can alleviate the course, reduce fever, and shorten the recovery time
  • Detoxification: Toxins from food and the environment can be mobilized under high doses of vitamin C; support detoxification organs, use binders or chelation

Contraindications: Do not use in children under 6 years of age. In case of impaired function of the kidneys, liver, heart, and albumin deficiency, an adjustment of the individual dose is recommended. Patients taking beta-blockers have an increased risk of a decompensated cardiovascular reaction, as beta-blockers inhibit the effect of adrenaline (emergency medical treatment). Patients with a tendency to allergic reactions and/or with diseases based on histamine release (e.g., asthma) should be questioned about known allergens to them according to the principles of therapeutic duty of care.

Contraindications: Hyperthyroidism, Thalassemia, hemochromatosis. A high-dose vitamin C infusion can promote the release of iron from the body's stores. G6PDH deficiency can lead to acute hemolytic anemia, which is caused by the destruction of red blood cells. Laboratory parameters must be checked. There should be no history of asthma.

CAVE: Bronchoconstriction due to vitamin C is possible. In case of impaired kidney function, high-dose vitamin C can have a nephrotoxic effect.

Tip: To prevent vascular spasms, oral administration of calcium 500–1,000 mg with 1 liter of water 30 minutes before the infusion is recommended. In addition, Magnesium Injekt 200 mg or Magnesium Injekt 1,000 mg is recommended parenterally.

Application: i.v., 15 g to be diluted in 500 ml of body-temperature Ringer's lactate solution. To prevent vascular spasms, supplement the carrier solution with Magnesium Injekt 200 mg. The vitamin C dose can be increased successively up to a vitamin C plasma level of 300–500 mg/dl (measurement on the day of the infusion). With vitamin C 150 g, a vitamin C plasma level of over 500 mg/dl was measured. The carrier solution should be reduced by the fluid content in which the vitamin C is dissolved. The infusion should always be prepared fresh. Dosage: 1–3 g vitamin C per kg body weight.

Note for doctors and therapists: In principle, the doctor/therapist determines the indication in individual prescriptions. The suggestion is merely a recommendation for a therapy option, whereby the dosage and frequency of application are solely at the discretion of the doctor/therapist. The treating therapist is responsible for the treatment and must individually check and assess the respective application for each patient before the start of treatment.

Shipping Information

NATIONAL:

  • Standard shipping: €9.95 incl. VAT
  • Free shipping on orders over €200.00 (does not apply to refrigerated goods and express shipments)
  • Refrigerated and express shipping: €25.95 incl. VAT

Note: If individual products are unavailable, partial deliveries may occur, incurring no additional shipping costs.
Any requested partial deliveries will be charged.

WITHIN THE EU:
For shipments to countries in EU Zone 1, we charge logistics costs of €75.00 (incl. VAT).

For shipments to countries in EU Zone 2, we charge logistics costs of €105.00 (incl. VAT).

THIRD COUNTRIES:
The customer is asked to inquire about the logistics costs incurred for the respective country.

References

We have researched the literature with the greatest possible care. Nevertheless, we accept no liability for the completeness and up-to-dateness of the study information. Many of the therapy options mentioned in the product information are based on findings obtained from animal or human cell cultures, animal experiments, observational studies, and to a lesser extent, randomized controlled trials (RCTs). The body of research on complementary medicines is subject to continuous development, which can sometimes lead to differing results. We therefore recommend that therapists always carefully review the current research before using such preparations.